MYLAN G1 (Glipizide 5 mg)
Pill imprint MYLAN G1 has been identified as Glipizide 5 mg.
Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 5 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for MYLAN G1 (Glipizide 5 mg)
Glipizide
- Imprint:
-
MYLAN G1
- Strength:
- 5 mg
- Color:
- White
- Size:
- 8.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Sulfonylureas
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-1105
- Inactive Ingredients:
- silicon dioxide colloidal
lactose anhydrous
microcrystalline cellulose
pregelatinized starch
stearic acid
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0810 | UDL Laboratories Inc |
Note: Inactive ingredients may vary.
More resources
Glipizide is associated with the treatment of:
Search Again
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
